<html>
<body bgcolor=fffff0 text=navy><!--'"</title></head>-->

<script type="text/javascript">
//OwnerIQ
var __oiq_pct = 50;
if( __oiq_pct>=100 || Math.floor(Math.random()*100/(100-__oiq_pct)) > 0 ) {
var _oiqq = _oiqq || [];
_oiqq.push(['oiq_addPageBrand','Lycos']);
_oiqq.push(['oiq_addPageCat','Internet > Websites']);
_oiqq.push(['oiq_addPageLifecycle','Intend']);
_oiqq.push(['oiq_doTag']);
(function() {
var oiq = document.createElement('script'); oiq.type = 'text/javascript'; oiq.async = true;
oiq.src = document.location.protocol + '//px.owneriq.net/stas/s/lycosn.js';
var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(oiq, s);
})();
}

/////// Google Analytics
var _gaq = _gaq || [];
_gaq.push(['_setAccount', 'UA-21402695-21']);
_gaq.push(['_setDomainName', 'angelfire.com']);
_gaq.push(['_setCustomVar', 1, 'member_name', 'bc/brentcopeland', 3]);
_gaq.push(['_trackPageview']);
(function() {
  var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
  ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
  var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
})();

////// Lycos Initialization /////////////////////
var lycos_ad = Array();
var lycos_search_query = "";
var lycos_onload_timer;

var cm_role = "live";
var cm_host = "angelfire.lycos.com";
var cm_taxid = "/memberembedded";
var angelfire_member_name = "bc/brentcopeland";
var angelfire_member_page = "bc/brentcopeland/quotes/abashi/jan1000.html";
var angelfire_ratings_hash = "1565346393:c5532ba07223d36a77826ef30060007b";

var lycos_ad_category = {"dmoz":"health\/addictions","ontarget":"&CAT=health&L2CAT=diseases%20and%20conditions&L3CAT=substance%20abuse","find_what":"email abuse"};

var lycos_ad_remote_addr = "95.216.200.73";
var lycos_ad_www_server = "www.angelfire.lycos.com";
var edit_site_url = "www.angelfire.lycos.com/landing/landing.tmpl?utm_source=house&utm_medium=landingpage&utm_campaign=toolbarlink";

</script>
<script type="text/javascript" src="http://scripts.lycos.com/catman/init.js"></script>

<script type='text/javascript'>
 var googletag = googletag || {};
 googletag.cmd = googletag.cmd || [];
 (function() {
   var gads = document.createElement('script');
   gads.async = true;
   gads.type = 'text/javascript';
   var useSSL = 'https:' == document.location.protocol;
   gads.src = (useSSL ? 'https:' : 'http:') +
     '//www.googletagservices.com/tag/js/gpt.js';
   var node = document.getElementsByTagName('script')[0];
   node.parentNode.insertBefore(gads, node);
 })();
</script>


<script type='text/javascript'>
 googletag.cmd.push(function() {
   googletag.defineSlot('/95963596/ANG_300x250_dfp', [300, 250], 'div-gpt-ad-1450207484070-0').addService(googletag.pubads());
   googletag.enableServices();
 });
</script>

<script type='text/javascript'>
 googletag.cmd.push(function() {
   googletag.defineSlot('/95963596/ANG_above_728x90_dfp', [728, 90], 'div-gpt-ad-1450207484070-1').addService(googletag.pubads());
   googletag.enableServices();
 });
</script>

<script type='text/javascript'>
 googletag.cmd.push(function() {
   googletag.defineSlot('/95963596/ANG_below_728X90_dfp', [728, 90], 'div-gpt-ad-1450207484070-2').addService(googletag.pubads());
   googletag.enableServices();
 });
</script>


<script type="text/javascript">
(function(isV) {
    if (!isV) {
        return;
    }

    //this.lycos_search_query = lycos_get_search_referrer();
    var adMgr = new AdManager();
    var lycos_prod_set = adMgr.chooseProductSet();
    var slots = ["leaderboard", "leaderboard2", "toolbar_image", "toolbar_text", "smallbox", "top_promo", "footer2","slider"];
    var adCat = this.lycos_ad_category;
    adMgr.setForcedParam('page', (adCat && adCat.dmoz) ? adCat.dmoz : 'member');

    if (this.lycos_search_query) {
        adMgr.setForcedParam("keyword", this.lycos_search_query);
    } 
    else if (adCat && adCat.find_what) {
        adMgr.setForcedParam('keyword', adCat.find_what);
    }

    for (var s in slots) {
        var slot = slots[s];
        if (adMgr.isSlotAvailable(slot)) {
            this.lycos_ad[slot] = adMgr.getSlot(slot);
        }
    }


    adMgr.renderHeader();
    adMgr.renderFooter();
}((function() {
    var w = 0, h = 0, minimumThreshold = 300;
    if (top == self) {
        return true;
    }

    if (typeof(window.innerWidth) == 'number' ) {
        w = window.innerWidth;
        h = window.innerHeight;
    }
    else if (document.documentElement && (document.documentElement.clientWidth || document.documentElement.clientHeight)) {
        w = document.documentElement.clientWidth;
        h = document.documentElement.clientHeight;
    }
    else if (document.body && (document.body.clientWidth || document.body.clientHeight)) {
        w = document.body.clientWidth;
        h = document.body.clientHeight;
    }

    return ((w > minimumThreshold) && (h > minimumThreshold));
}())));



window.onload = function() {
    var f = document.getElementById("lycosFooterAd");
    var b = document.getElementsByTagName("body")[0];
    b.appendChild(f);
    f.style.display = "block";
    document.getElementById('lycosFooterAdiFrame').src = '/adm/ad/footerAd.iframe.html';

    // Slider Injection
    (function() {
        var e = document.createElement('iframe');
        e.style.border = '0';
        e.style.margin = 0;
        e.style.display = 'block';
        e.style.cssFloat = 'right';
        e.style.height = '254px';
        e.style.overflow = 'hidden';
        e.style.padding = 0;
        e.style.width = '300px';
    })();


    // Bottom Ad Injection
    ( function() {
        var b = document.getElementsByTagName("body")[0];

        var iif = document.createElement('iframe');
        iif.style.border = '0';
        iif.style.margin = 0;
        iif.style.display = 'block';
        iif.style.cssFloat = 'right';
        iif.style.height = '254px';
        iif.style.overflow = 'hidden';
        iif.style.padding = 0;
        iif.style.width = '300px';
        iif.src = '/adm/ad/injectAd.iframe.html';
        
        var cdiv = document.createElement('div');
        cdiv.style = "width:300px;margin:10px auto;";
        cdiv.appendChild( iif );
        if( b )
        {
            b.insertBefore(cdiv, b.lastChild);
        }
    })();

}


</script>

<style>
	#body .adCenterClass{margin:0 auto}
</style>

<div style="background:#abe6f6; border-bottom:1px solid #507a87; position:relative; z-index:9999999">

    <div class="adCenterClass" style="display:block!important; overflow:hidden; width:916px;">
        <a href="http://www.angelfire.lycos.com/" title="Angelfire.com: build your free website today!" style="display:block; float:left; width:186px; border:0">
        <img src="/adm/ad/angelfire-freeAd.jpg" alt="Site hosted by Angelfire.com: Build your free website today!" style="display:block; border:0" />
        </a>
        <div id="ad_container" style="display:block!important; float:left; width:728px ">
            <script type="text/javascript">document.write(lycos_ad['leaderboard']);</script>
        </div>
    </div>
</div>

<!-- ///////////////////////////////////// -->
<script type="text/javascript">document.write(lycos_ad['slider']);</script>


<div id="lycosFooterAd" style="background:#abe6f6; border-top:1px solid #507a87; clear:both; display:none; position:relative; z-index:9999999">
<div class="adCenterClass" style="display:block!important; overflow:hidden; width:936px;">
	<div id="aflinksholder" style="float:left; width:186px;">
        <a href="http://www.angelfire.lycos.com/" title="Angelfire.com: build your free website today!" style="display:block; border:0">
            <img src="/adm/ad/angelfire-freeAd2.jpg" alt="Site hosted by Angelfire.com: Build your free website today!" style="display:block; border:0" />
        </a>
    </div>
    <iframe id="lycosFooterAdiFrame" style="border:0; display:block; float:left; height:96px; overflow:hidden; padding:0; width:750px"></iframe>
</div>
</div>





<!--- The Datacom Ad Network [http://www.datais.com] --->
<center>
<a href="http://ads.datais.com/ads/ad.cgi?bcope1-link35&cnc=true" target="_top">
<img src="http://ads.datais.com/ads/ad.cgi?bcope1-ad35&cnc=true" border="0"
   alt="Click here to visit our sponsor" width="468" height="60"></a><br>
<font face="arial" size="1"><a href="http://www.datais.com">The Datacom Ad Network</a></font>
</center>
<!------------------------------------------------------>

<TD width=18% valign=top>
	<FONT SIZE="2" face="Verdana, Arial" color="red"><B>Abashi</b></font><BR><FONT SIZE="1" face="Verdana, Arial">Station Member</FONT>
</td>
<TD>
<IMG SRC="http://boards.station.sony.com/everquest/posticon.gif" BORDER=0>
<FONT SIZE="2" FACE="Verdana, Arial">
<FONT SIZE="1" color="#ff9900" face="Verdana, Arial">posted 01-10-2000 11:06 PM &nbsp;&nbsp;&nbsp;
&nbsp; &nbsp; &nbsp;&nbsp;
</FONT><HR>&gt;&gt;&gt;1) LOH should never Fizzle or be interupted. <P>Nothing in EverQuest is 100%, not even a Gate Potion.  It’s not meant to be.  <P>&gt;&gt;&gt;2) Increase Bash Skill cap. Most say to 200. <P>200 would make them equal to warriors in that respect.  Paladins and Shadowknights give up some of the combat prowess of warriors in exchange for spells. <P>&gt;&gt;&gt;3) Improve Armor Class and remove the High Level Armor Class cap. <P>Again, see the comment about warriors.  <P>&gt;&gt;&gt; 4) Improve melee damage to be comparable to other Hybrids. <P>They are better than bards, and equal with rangers in 1HS and 2HS.  <P>&gt;&gt;&gt;5) Increase Increase defense, parry, dodge, and ripoiste skill caps. <P>See comments about warriors<P>&gt;&gt;&gt;6) Increase Taunt skill cap. <P>See comments about warriors<P>&gt;&gt;&gt;7) Improve and/or implement better weapons. <P>You have a point. It’s being done.<P>&gt;&gt;&gt;8) Implement Better shileds w/ procs when bashing. <P>Don’t know about shields Proc’ing, but I suppose anything is possible.<P>&gt;&gt;&gt;9) Improve our quest and make the reward worthy of the quest. <P>Which quest?<P>&gt;&gt;&gt;10) Remove Disarm or increase skill so it is usable.<P>This is probably as good as Disarm is going to get. <P>Now, having said all of that, I want to stress that we don’t go around making sweeping balance changes on a “would be nice” basis.  I’m sure every class out there can come up with 10 or 20 things they would like changed about their class.  Hey, we can too.  But the question is, why?  What is it that SKs and Paladin’s can’t do that they should be able to? Most of their combat caps are the same as warriors.  They are every bit as good with a sword as a warrior.  They aren’t going to get Dual Wield, nor the hitpoints of a warrior, however they do get spells.  If the spells that you get aren’t worth what you lose by virtue of hitpoints and a few combat skills, then you can choose not to play a Paladin or an SK. <P>Yes, I’m sure that everyone would be happy if we went and made these changes above, for about 2 weeks until warriors and rogues figure that they are getting the raw end of the deal.  So tell me, what is the compelling reason to change all of these things? <P>-Gordon<BR></FONT><P align=right><FONT SIZE="1" color="#ff9900" face="Verdana, Arial"></font></P></td></tr><tr bgcolor="#003333"><P>
<TD width=18% valign=top>
	<FONT SIZE="2" face="Verdana, Arial" color="red"><B>Abashi</b></font><BR><FONT SIZE="1" face="Verdana, Arial">Station Member</FONT>
</td>
<TD>
<IMG SRC="http://boards.station.sony.com/everquest/posticon.gif" BORDER=0>
<FONT SIZE="2" FACE="Verdana, Arial">
<FONT SIZE="1" color="#ff9900" face="Verdana, Arial">posted 01-10-2000 11:25 PM &nbsp;&nbsp;&nbsp;
&nbsp; &nbsp; &nbsp;&nbsp;
</FONT><HR>&gt;&gt;&gt;Anyway..Abashi..Don't make the same mistake you did with alchemy. Do a REAL test and comparison before saying we do the same damage as a ranger. That may be what you WANTED us to do..but that's certainly not what we do as it stands now.<P>Are you saying that a level 50 paladin with maxed skills does less sword damage than a level 50 ranger with maxed skills wielding an identical weapon?  The numbers don't seem to support that, but please let me know if it's the case.  The caps are the same according to where I was looking.<P>-Gordon<BR></FONT><P align=right><FONT SIZE="1" color="#ff9900" face="Verdana, Arial"></font></P></td></tr><tr bgcolor="#003333"><P>
<TD width=18% valign=top>
	<FONT SIZE="2" face="Verdana, Arial" color="red"><B>Abashi</b></font><BR><FONT SIZE="1" face="Verdana, Arial">Station Member</FONT>
</td>
<TD>
<IMG SRC="http://boards.station.sony.com/everquest/posticon.gif" BORDER=0>
<FONT SIZE="2" FACE="Verdana, Arial">
<FONT SIZE="1" color="#ff9900" face="Verdana, Arial">posted 01-10-2000 11:35 PM &nbsp;&nbsp;&nbsp;
&nbsp; &nbsp; &nbsp;&nbsp;
</FONT><HR>&gt;&gt;&gt;YES, that's what I'm saying<P>Can anyone confirm this?<P>I'll also doublecheck the caps tomorrow when the keeper o' the caps is in.  It's possible that I'm reading the info from the wrong location.  However, assuming I'm not, two characters with the same stats and skills wielding the same weapon at the same level *should* do roughly the same damage. <P>Now if that's not the case here, please follow-up.<P>-Gordon<BR></FONT><P align=right><FONT SIZE="1" color="#ff9900" face="Verdana, Arial"></font></P></td></tr><tr bgcolor="#003333">
</body>
</html>
